This article was originally published on April 23, 2020, when we first saw the ads from Paul Mampilly — most recently this has been more aggressively pitched with the idea of the “12 million mile battery,” so we’re re-posting our solution for you. The ad has not changed and is still dated April 2020, and […]
Today I thought I’d take a look at the latest teaser pitch from Extreme Fortunes, a “no refunds” monthly stock-picking newsletter that they’re currently pricing at $2,995/yr., positioned as the “upgrade” letter from Paul Mampilly’s Profits Unlimited over at Banyan Hill and focused more, they indicate, on smaller-cap stocks. Mampilly, by the way, headlines no […]
Does anyone know why Harry Dent sold Dent Research? Maybe he was just done with it? I was a lifetime member, and I liked some of their analysts. Now I’m handed off to Paul Mampilly and Banyan Hill. Is there anybody worth listening to at Banyan Hill? I’m not excited about digging through all their […]
You’ve almost certainly seen these ads from Paul Mampilly, the ones that start with the headline “These Warehouses Hold the Key to a $3.1 Trillion Dollar Revolution…” The ad has been running since at least the Summer of 2018, and has not really been updated at all in the interim as far as I can […]
A version of this article was published on January 13, 2020, when Mampilly’s ads first called this his “#1 Stock for 2020”, and though the ad is unchanged we’re seeing it a lot again now — most recently, the ads from Banyan Hill now say that this “$10 Stock Gets ‘All In’ Buy Alert on […]
I received an email and was wondering if anyone else had a South Carolina manufacturing company that’s around $10 share. Right now, it’s trading right around $10. But I think it could soar to $50 … and then potentially even $100. John: So … a 1,000% gain. That’s incredible. You know, most people hope for […]
Every year we call out a “turkey” stock teaser around Thanksgiving time and poke a bit of fun at some terrible investment ideas… … so it seems only fair to highlight a few winners as well, and this week, when we’re otherwise closed for the holiday, seems a good time to spread some cheer and […]
Today we’ve got a bit of a quickie for you, mostly just because the clues that were dropped were extremely limited… but it also happens to be a stock I’ve looked at before, so I thought it was worth taking a second look today. Paul Mampilly over the weekend was peddling his True Momentum service […]
One of half a dozen Paul Mampilly-connected newsletters at Banyan Hill, this one is a “trading service” that attempts to pick a couple midsize stocks each month that have “true momentum” (which seems to be a qualitative assessment of the business prospects, not a market momentum measure).
Geothermal is back! Paul Mampilly is circulating his “Ocean of Energy Under all 50 States” pitch once more, so it’s time to take another look. His ad is almost exactly the same as it was when we first covered it in March, 2017, but I’m sure the story must have changed a bit along the […]
This article was originally published on Halloween, 2018, but we’re getting a ton of new questions about it so they must be running the ad heavily again. The ad has NOT been updated in any meaningful way, but some significant things have changed for this stock over the past year (though the stock price is […]
Here is partially what he says. Any idea of what stock he is talking about? Is it one that he has pumped in earlier announcements? Dear Joseph, I wanted to reach out while there’s still time. Tomorrow I will be issuing my biggest trade alert of the year (on a $5 stock) for members of […]
We tend to get a lot of questions when there’s a new Paul Mampilly ad pounding the pavement, presumably because Banyan Hill tries so hard to reach pretty much everyone who has a pulse and an email address (with the latter being far more important than the former), so we’ll jump in on this Monday […]
Happy New Year to the best readers in cyberspace! I hope your 2019 is fabulous… and that you don’t have too many heart palpitations following the last couple weeks of market and political brinksmanship. I haven’t written to you in a while, thanks to my much-appreciated time away with family and friends in the mountains, […]
Paul Mampilly’s high-end (~$5,000 one time fee plus $499 annual maintenance, no refunds) advisory that aims to “turn $10,000 into a $10 million fortune” — monthly stock picks with analytical commentary.
Paul Mampilly is out with a teaser pitch for his Profits Unlimited newsletter from Banyan Hill, which is the entry-level ($97/yr) stock picking letter for that publisher (which used to be called the Sovereign Society). I first covered this for the Irregulars last summer, but we’re still getting a lot of questions so we opened […]
I know a lot of my readers follow Paul Mampilly pretty ardently, partly because of the fact that his publisher, Banyan Hill, is one of the more aggressive promoters in newsletterdom these days, and partly because he made some very strong picks with his first, heavily promoted service — particularly the teased pick of STMicroelectronics […]
I’ve gotten quite a few questions about this spiel, which was for a recommendation that Mampilly was supposed to release yesterday (and presumably did) to his Extreme Fortunes subscribers, so I’m taking a look… despite the fact that I’m a little sick of writing about bitcoin. Extreme Fortunes is the “high end” newsletter Mampilly writes […]
Fridays are the day I write for you, my dear Irregular friend, so this time you’re getting a teaser solution that I’ve been inspired to write about today, plus a few updates on my Real Money Portfolio stocks. First, those (pretty minor) updates… One of the worst-performing stocks I own over the past year or […]
My eyes lit up when I saw the latest ad from Paul Mampilly for his Profits Unlimited newsletter — more geothermal! Woohoo! Even the ad looked familiar — we saw quite a few of those ‘heat map’ images of the US five or ten years ago when geothermal stocks “heated up,” so it gave me […]
Paul Mampilly is out with a new promo for his Extreme Fortunes newsletter, making this absurd promise: “Anyone who joins my research service Extreme Fortunes, and invests $10,000 following my recommendations, will have the chance to earn a profit of $100,000… in the next year.” So before we begin, let’s throw away that possibility. You’re […]
“Upgrade” newsletter from Paul Mampilly at Banyan Hill, focuses on targeting 1,000% gains “on every single trade” in small cap stocks that are “disruptive.”
Today, for your holiday reading pleasure, we’re re-sharing a teaser solution that’s still being asked about (and apparently still being heavily promoted by the Sovereign Society folks). The original solution to this teaser appeared in a Friday File commentary, so some of you may not have seen it. I’ve excerpted most of the teaser solution […]
A few things to blather on about for you today — a teaser, a new mutual fund I’ve been following that has some appeal (and some of my money now), and some quick updates on my portfolio. First, though, I want to call attention to our discussions here at Stock Gumshoe. Most readers will never […]
Relatively new letter in 2016, priced as an entry level letter, with goal to “get in on the ground floor in innovative companies that are just about to see explosive growth.” Mampilly previously worked on letters for Palm Beach, Stansberry and Agora Financial over the past four years. Banyan Hill (the publisher) used to be […]
I’ve got a few stocks to mention in the medical space this week — one to update that’s in my portfolio, one to confirm as a teaser pick (since folks keep asking) after several Gumshoe readers discussed it last week, and one to note as a teaser idea that’s being pushed pretty heavily (though the […]
How about something on Stansberry’s latest – “Pinpoint Surgery” stock?
This is a quickie for you, I came across it and don’t want to write up a full look at the company but I thought some of you would like the teaser solution. The ad’s from Agora Financial’s FDA Trader, which has been touting this “magic calendar” idea of investing in stocks around (mostly) PDUFA […]
That’s right, the end of obesity. That’s what’s being touted by the new letter that as far as I can tell was just launched moments ago by Agora, which they’re calling FDA Trader and for which they apparently hired away Paul Mampilly from the Palm Beach Letter (OK, they didn’t really “hire him away” — […]
Biotech trading advisory/newsletter.
It’s been a few months since I last wrote about a teaser pitch from the Palm Beach Letter, the “entry level” letter from Common Sense Investing that was started in the last year or so by ex-Stansberry pundit Tom Dyson and marketing guru Michael Masterson/Mark Ford. (Yes, I say “entry level” even though this is […]